2016
DOI: 10.1007/s00381-016-3279-8
|View full text |Cite
|
Sign up to set email alerts
|

Clinical practice audit concerning antimicrobial prophylaxis in paediatric neurosurgery: results from a German paediatric oncology unit

Abstract: This first comprehensive audit of PAP in paediatric oncology patients undergoing neurosurgery outlines significant opportunities to improve clinical practice in terms of correct dosing, the correct choice of the antibiotic, a correct timing schedule and a shorter duration of PAP. In addition, our results illustrate in detail the challenges in clinical practice when an evidence-based approach to improve a standard workflow has to be implemented.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 37 publications
0
1
0
Order By: Relevance
“…The administration of prophylactic antibiotics as in our protocol is evenly controversial, as this may cause resistance and side effects like Clostridium difficile colitis. However, even though the meta-analysis by Fried et al [ 12 ] recommended to only give one dose of systemic antibiotics prior to EVD insertion, supported by some other prospective and retrospective case studies, as well as a few randomized trials on this question, none of these studies did investigate the very vulnerable patient population of pediatric posterior fossa tumors [ 16 , 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…The administration of prophylactic antibiotics as in our protocol is evenly controversial, as this may cause resistance and side effects like Clostridium difficile colitis. However, even though the meta-analysis by Fried et al [ 12 ] recommended to only give one dose of systemic antibiotics prior to EVD insertion, supported by some other prospective and retrospective case studies, as well as a few randomized trials on this question, none of these studies did investigate the very vulnerable patient population of pediatric posterior fossa tumors [ 16 , 17 ].…”
Section: Discussionmentioning
confidence: 99%